Your session is about to expire
← Back to Search
BAT Imaging for Aging (BATSP Trial)
N/A
Waitlist Available
Led By Paul Coen, PhD
Research Sponsored by Translational Research Institute for Metabolism and Diabetes, Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights
BATSP Trial Summary
This trialseeks to find an accurate way to measure body fat using MRI for people of all ages.
BATSP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Collection of imaging of BAT by magnetic resonance imaging from 10 participants in each of young and old study groups.
BATSP Trial Design
2Treatment groups
Experimental Treatment
Group I: Young groupExperimental Treatment3 Interventions
20-40 years of age
Group II: Old groupExperimental Treatment3 Interventions
60-80 years of age
Find a Location
Who is running the clinical trial?
Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,573 Total Patients Enrolled
1 Trials studying Aging
50 Patients Enrolled for Aging
AdventHealth Translational Research InstituteLead Sponsor
48 Previous Clinical Trials
20,157 Total Patients Enrolled
2 Trials studying Aging
81 Patients Enrolled for Aging
Paul Coen, PhDPrincipal InvestigatorStudy principal investigator
5 Previous Clinical Trials
167 Total Patients Enrolled
1 Trials studying Aging
50 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have taken strong anti-inflammatory medication prescribed by a doctor within the past 6 weeks before the screening.You have experienced very bad diarrhea, nausea, or vomiting that was not under control within the past 3 months.You have a history of regularly drinking more than 3 alcoholic drinks per day or using drugs within the past 5 years.You are currently trying to lose weight or make lifestyle changes.You have had a major heart attack or stroke within the past 6 months, or you have a history of congestive heart failure, or your heart health is found to be concerning during the screening tests.You are unable to tolerate being inside an MRI machine or you have a fear of confined spaces (claustrophobia).You currently have cancer or an autoimmune disease that is actively causing symptoms.
Research Study Groups:
This trial has the following groups:- Group 1: Young group
- Group 2: Old group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To whom is eligibility for this experimental treatment being extended?
"Subjects aged 20 to 80 can apply for this research study, of which 24 successful applicants will be selected."
Answered by AI
Are there any openings in this experiment for participants?
"According to clinicaltrials.gov, this experiment is not presently enrolling patients as the last update was on November 16th 2022. Despite its close-out status, there are currently 245 other trials actively looking for participants in related areas of research and medicine."
Answered by AI
Does this investigation accept participants of younger ages?
"This experiment is open to patients between the ages of twenty and eighty."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger